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Abstract
Purpose—Golden retriever muscular dystrophy (GRMD) is a widely used canine model of 
Duchenne muscular dystrophy (DMD). Recent studies have shown that magnetic resonance 
imaging (MRI) can be used to non-invasively detect consistent changes in both DMD and GRMD. 
In this paper, we propose a semi-automated system to quantify MRI biomarkers of GRMD.
Methods—Our system was applied to a database of 45 MRI scans from 8 normal and 10 GRMD 
dogs in a longitudinal natural history study. We first segmented six proximal pelvic limb muscles 
using two competing schemes: 1) standard, limited muscle range segmentation and 2) semi-
automatic full muscle segmentation. We then performed pre-processing, including: intensity 
inhomogeneity correction, spatial registration of different image sequences, intensity calibration of 
T2-weighted (T2w) and T2-weighted fat suppressed (T2fs) images, and calculation of MRI 
biomarker maps. Finally, for each of the segmented muscles, we automatically measured MRI 
biomarkers of muscle volume and intensity statistics over MRI biomarker maps, and statistical 
image texture features.
Results—The muscle volume and the mean intensities in T2 value, fat, and water maps showed 
group differences between normal and GRMD dogs. For the statistical texture biomarkers, both 
the histogram and run-length matrix features showed obvious group differences between normal 
and GRMD dogs. The full muscle segmentation shows significantly less error and variability in 
the proposed biomarkers when compared to the standard, limited muscle range segmentation.
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Conclusion—The experimental results demonstrated that this quantification tool can reliably 
quantify MRI biomarkers in GRMD dogs, suggesting that it would also be useful for quantifying 
disease progression and measuring therapeutic effect in DMD patients.
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Duchenne muscular dystrophy; golden retriever muscular dystrophy; MRI; canine model; 
segmentation; statistical texture analysis
I.INTRODUCTION
Duchenne muscular dystrophy (DMD) is a fatal, X-linked, muscle disorder characterized by 
progressive degeneration of skeletal and cardiac muscle [1]. It is the most common form of 
muscular dystrophy, affecting approximately 1 in 3,500 live born males [2, 3]. DMD is 
caused by mutations in the DMD gene, which encodes the cytoskeletal protein dystrophin. 
Proximal leg muscle weakness is generally the first observed clinical manifestation of DMD. 
The ensuing progressive muscle weakness usually leaves affected boys severely disabled by 
their early teenage years, and results in death due to respiratory and cardiac failure [2]. 
Currently, no therapy halts or reverses progression of DMD. Although cellular and gene 
therapies are promising, key questions must first be addressed in relevant animal models. 
Spontaneous forms of X-linked muscular dystrophy due to dystrophin deficiency have been 
characterized in mice, [4] cats, [5] and dogs. [6, 7] Because golden retriever muscular 
dystrophy (GRMD) dogs develop progressive and fatal disease strikingly similar to the 
human condition, this model has increasingly been used in preclinical trials [8].
Although muscle biopsy has been widely used in the diagnosis of muscle diseases including 
DMD, the invasiveness limits its use and now most patients are diagnosed using molecular 
methods. As a result, non-invasive outcome measures, especially quantitative methods, are 
needed for studies in animal models and in DMD patients. Magnetic resonance imaging 
(MRI) has been used as to provide data on disease progression in both natural history and 
treatment trials for GRMD [9, 10, 11] and DMD [12, 13, 14]. Observed MRI changes in 
DMD include an increase in T2 and decrease in T1 relaxation times due to accumulation of 
fat in affected muscles. There is an associated increase in whole body fat and decrease in 
muscle mass [12, 15]. These MRI imaging features have been successfully correlated with 
functional measurements [16, 17]. In fact, one study suggested that MRI is more sensitive 
than functional tests in predicting disease progression [15]. The potential role of MRI as a 
biomarker in the GRMD model has also been reported [9, 10, 11]. In the Thibaud et al. study 
[10], 2-month-old GRMD and carrier dogs were assessed. GRMD dogs had an abnormally 
high T2-/T1-weighted signal ratio, greater T2-weighted image heterogeneity, and more 
enhanced muscle signal on T1-weighted images after Gd-DTPA injection compared to heath 
controls. A subsequent study of 3-month-old to 7-year-old muscular dystrophy dogs by 
Kobayashi et al. [9] demonstrated increased T2 values and fat suppressed T2-weighted 
intensity, as well as greater enhancement with gadolinium, consistent with inflammation and 
necrosis. Yokota et al.’s study [11] contrasted muscular dystrophic dogs treated with a 
morpholino cocktail with both untreated muscular dystrophic dogs and wild-type littermates 
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from 2 months to 5 years of age. Treated muscular dystrophic dogs had consistently 
decreased T2 values compared to those that were untreated.
In existing DMD and GRMD studies, muscle segmentation and MRI-based biomarker 
quantification are manually driven. Because full manual assessment is cumbersome, time 
consuming and subject to rater errors, computerized quantification methods are needed for 
advancing MRI biomarkers as objective surrogate outcome measures for pre-clinical and 
clinical trials. In this paper, we present a novel semi-automatic MRI quantification tool that 
provides potential imaging biomarkers for monitoring disease progression in pre-clinical and 
clinical trials of GRMD and DMD. In addition, we propose new run-length matrix based 
MRI statistical texture analysis technique to create statistical texture biomarkers, which 
discriminate between normal and GRMD dogs.
II.METHOD
II.1. Study Subjects
The database used in this study included 10 GRMD and 8 normal dogs. Data from MRI 
were included in a range of phenotypic tests performed over their first year of life. The 
proximal pelvic limbs of all dogs were scanned at approximately 3 and 6 months of age. 
Additional studies were completed at 9 months in five GRMD and four normal dogs. Totally 
45 MRI scans were acquired.
All the dogs were produced through a GRMD colony maintained at the University of North 
Carolina at Chapel Hill (UNC-CH) (PI, Kornegay). Dogs were scanned on a Siemens 3T 
Allegra Head-Only MRI scanner with a circular polarization (CP) head coil or Siemens 3T 
Tim Trio Whole-Body MRI scanner with a 32-channel body coil at the UNC Biomedical 
Research Imaging Center (BRIC). Dogs were anesthetized, placed on an MRI gantry in the 
sternal (prone) position with the pelvic limbs extended and positioned in the coil centered at 
the midpoint of the femur.
The image protocol of the MRI scans is listed in Table 1. T2-weighted (T2w) image 
sequence [Fig. 1 (a)] was acquired using a variable-flip-angle turbo spin echo (TSE) 
sequence. No fat saturation magnetization preparation was applied. T2-weighted fat 
suppressed (T2fs) images sequence were then acquired using the same variable-flip-angle 
TSE sequence [Fig. 1 (b)] with the same scanning parameters except that a fat saturation 
preparation was applied. During the fat saturation procedure, a frequency-selection pulse 
was applied to excite the fat; dephasing gradient pulses were applied immediately after the 
frequency-selection pulse to spoil the fat signal. Thus, the remaining signal contained close 
to zero contribution from fat
To obtain T2 value maps, a multi-slice, ten-echo Carr-Purcell-Meiboom-Gill (CPMG) 
sequence [T2FIT, Fig. 1 (c)] was applied with the parameters listed in Table 1. To make the 
acquisition time manageable, the T2FIT only covered the mid-femur section of the proximal 
pelvic limbs. The computation of T2 value maps is described in detail in section II.2.2.2.
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II.2. Image Analysis Method
Our biomarker quantification scheme is composed of three modules: muscle segmentation, 
pre-processing, and biomarker analysis. As a prerequisite, we first segmented six major 
proximal pelvic limb muscles of dogs in the MRI images. Then, the process continued with 
several preprocessing steps and the calculation of the MRI biomarker including texture-
based biomarkers. Finally, regional statistics of the MRI biomarkers were calculated for 
each segmented muscle and these biomarkers were assessed in the context of GRMD disease 
progression.
II.2.1. Muscle segmentation—In this study, we quantified MRI-based biomarkers of 
GRMD dogs and normal littermates in six proximal pelvic limb muscles: cranial sartorius 
(CS), rectus femoris (RF), semitendinosus (ST), biceps femoris (BF), gracilis (GR), and 
adductor magnus (AD). These muscles were selected to have a balanced representation of 
flexors and extensors, variable sizes and variable histopathological progression, based on 
our prior pathologic studies [6, 18]. For instance, histopathologic changes in the CS occur 
earlier than those in the vastus lateralis [19]. As the anatomical structures of the left and 
right limbs have a high degree of bilateral symmetry, i.e. differences between the left and a 
mirrored right leg of the same subject are expected to be small when compared to inter-
subject differences, we focused on the left limb in this research for the purpose of tool 
development and feasibility/validation analysis. We expect that muscle segmentation of the 
right limb and the subsequent biomarker quantification can be obtained by mirroring the MR 
images and by applying the processing framework for the left limb.
In existing DMD and GRMD MRI studies, muscles were usually segmented manually. To 
reduce the workload of muscle segmentation, the muscles are generally segmented in a 
limited range, typically mid-section in the transverse view. For instance, in our previous 
work [20], we manually segmented the muscles in five slices close to the femoral mid-point. 
The midpoint of the femur was determined by first identifying the femoral head and condyle 
as the proximal and distal anatomical limits, respectively, and then dividing the distance 
between these landmarks in half. As the large majority of a muscle is excluded using such a 
limited segmentation approach, measurements of muscle volume as well as other biomarkers 
are quite likely inaccurate (see section III for our evaluation on this topic). To address this 
issue, we performed an interpolation-based semi-automatic whole muscle segmentation. 
First, prior to the segmentation, the MRI data were rigidly realigned to a standardized 
coordinate space, where transverse slices were perpendicular to the femur axis and the 
sagittal and dorsal slices were parallel to the lateral and cranial axes, respectively. An initial 
segmentation was then performed by three of the authors (ZF, YS, and JW), each manually 
delineating the outline of every muscle in every fifth slice only (per muscle, an average of 
24 manually-segmented slices) using the ITK-SNAP software (www.itksnap.org) [21]. The 
manual segmentation was performed independently, i.e., the raters were blinded to the 
diagnostic information of the dogs and blinded to segmentations from other raters. Thus, the 
manual segmentation of the muscles was unbiased. Figure 3 (a) shows the manual 
segmentation of the six muscles of a normal dog in a transverse slice. The segmentations of 
the remaining slices (4 slices between each 2 manually-segmented slices) were then 
interpolated via a straightforward linear interpolation scheme from the neighboring 
Wang et al. Page 4













manually-segmented slices. Figure 3 (b) shows the interpolated muscle volumes in three 
dimensional (3D) views. Given the non-folded appearance of proximal pelvic limb muscles, 
we did not expect a large error for such an interpolated segmentation approach.
Unlike the limited mid-femur range segmentations, this straightforward interpolation 
scheme allowed us to compute a set of MRI biomarkers, incorporating intensity information 
across most of the entire muscle’s length.
We created a reference dataset to assess the semi-automated segmentation method. ZF 
manually delineated the full muscles of CS, RF, and ST in the MRI scans of two normal 
dogs and two GRMD dogs. We used the biomarkers (Section II.2.3.) calculated in the 
manually segmented muscles as the reference standard. We employed the percent difference 
ratio D [Eq. (2)] of all biomarkers calculated in the evaluated muscle segmentation (Be) and 
reference muscle segmentation (Br, manual muscle segmentation) as the performance metric 
to measure agreement between our biomarker quantification tool and the reference standard.
2
II.2.2. Pre-processing—The pre-processing was divided into five steps: (1) intensity 
inhomogeneity correction, (2) calculation of T2 value map, (3) registration of T2w, T2fs, and 
T2 value maps, (4) intensity calibration of T2w and T2fs, and (5) calculation of MRI 
biomarker maps.
II.2.2.1. Intensity inhomogeneity correction: Intensity inhomogeneity refers to the slow, 
non-anatomic intensity variations of the same tissue in a MRI image, typically caused by B1 
inhomogeneity, receiver coil non-uniformity or static field inhomogeneity [22]. We used the 
N4 algorithm [23] [24] to correct for such intensity inhomogeneities. N4 aims at correcting 
intensity inhomogeneity by seeking the multiplicative bias field that maximizes the high 
frequency content in the intensity histogram.
II.2.2.2. Calculation of T2 value map: We calculated T2 value map on a voxel-by-voxel 
basis for the proximal pelvic limbs of dogs in the transverse plane of T2FIT by fitting an 
exponential decay curve to the signal intensity of the corresponding voxels using a linear-
least-squares curve-fitting algorithm [25]. In T2FIT, the intensity of a voxel as a function of 
echo time is fit to a monoexponential function [Eq. (1)].
1
where i is an index corresponding to the ith TE of the T2FIT and Ii(x,y,z) is the image 
intensity for the voxel (x,y,z) in the ith TE of the T2FIT. The monomial coefficient from the 
linear-least-square curve fit was weighted inversely and assigned to each voxel of T2 value 
map as the final T2 value map value. The dynamic range of the T2 value map was 16 bits.
The central slice of a T2 value map obtained from the T2FIT is shown in Fig. 1 (c). T2 value 
maps are sensitive to signal from both water and fat tissue. Thus, T2 value maps capture 
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changes in both fat and water content within muscles, such as those occurring due to disease 
progression. Furthermore, the T2 value maps are quantitative measurements (in ms) and not 
affected by the MR signal inhomogeneity. Thus, they can be directly employed for intra and 
inter-subject comparisons.
II.2.2.3. Image registration: Due to the possible presence of motion during the MRI 
acquisition, we co-registered the T2fs and T2 value maps to the T2w via standard rigid 
transformation using three translation parameters and three rotation parameters.
In the study presented in this paper, we used T2w as the fixed image as it provides better 
signal than the T2fs and higher resolution than the T2 value maps. We employed a mutual 
information metric [26] based implementation available within the Insight Segmentation and 
Registration Toolkit (ITK, www.itk.org) to register T2fs and T2 value maps to T2w for each 
MRI scan.
II.2.2.4. Intensity calibration: In contrast to the T2 value maps, T2w and T2fs are not 
inherently calibrated, so their intensity values cannot be directly compared across MRI scans 
from different subjects or even when acquired from the same subject at different times. To 
overcome this limitation, we calibrated the T2w and T2fs via an intensity-rescaling 
technique based on the mean intensity observed within subcutaneous fat regions. These fat 
regions were assumed to be composed of nearly pure fat in all dogs (independent of 
diagnosis). Because the fat signal is pre-saturated in T2fs, fat regions show very low 
intensity in T2fs but exhibit high intensity in T2w. For this calibration procedure, we first 
manually identified a subcutaneous fat region in three contiguous transverse slices at mid-
thigh of the proximal pelvic limb in the registered T2w and T2fs. The mean intensity of the 
subcutaneous fat region in calibrated T2w was then (arbitrarily) set to 1000 and the one in 
calibrated T2fs was set to 100. Thus, the intensities Ic of the calibrated T2w or T2fs were 
defined as:
Ic(x, y, z) = 900 / (m1 – m2) × I (x, y, z) + (100 × m1 – 1000 × m2) / (m1 – m2)
where I (x, y, z) is the intensity at voxel (x, y, z) in the non-calibrated T2w or T2fs and m1 
and m2 are the mean intensities of the subcutaneous fat regions in non-calibrated T2w and 
T2fs, respectively.
II.2.2.5. Calculation of MRI biomarker maps: To evaluate the importance of the fat and 
water signals in the MRI images, we first quantified the loss in intensity between intensity 
calibrated T2w and T2fs to compute an estimate of the fat signal in each voxel and thus 
create a fat map (FM):
FM (x, y, z) = IT2w (x, y, z) – IT2fs (x, y, z)
Because the fat signals were suppressed in the T2fs, the water signal in each voxel was 
simply estimated from the intensity of the voxel in the intensity calibrated T2fs image, 
allowing us to create a water map (WM) by
WM (x, y, z) = IT2FS (x, y, z)
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IT2w (x, y, z) and IT2fs(x, y, z) are the intensities of voxel (x, y, z) in the denoised and 
registered T2w and T2fs. Denoising was established via standard anisotropic diffusion 
smoothing [27]. Anisotropic diffusion is a technique to reduce image noise without 
removing significant edges, lines or other details that are important for the interpretation of 
the images. The performance of anisotropic diffusion smoothing is controlled by three 
parameters, the number of iterations, time step, and conductance, where the number of 
iterations and the time step are parameters used for controlling the smoothness of the image 
and conductance is used for controlling the edge contrast in the smoothed image. Without 
noise reduction, significant image noise may considerably impact the WM and FM map 
computation and could lead to incorrect water and fat signal related biomarkers as the FM is 
calculated via direct differences on the T2w and the T2fs images. However, the smoothing 
process may have side effects, such as the fusion of fat and muscle signals at the boundary 
of the subcutaneous fat and muscle regions. This problem can be reduced by using a 
relatively high conductance to enhance the contrast of different tissues in the smoothed 
image. In this study, we empirically selected the parameters for anisotropic diffusion 
smoothing by visually observing the smoothing effect in a subset of MRI scans (3 normal 
and 3 GRMD scans). The number of iterations was set to 5, time step was set to 0.625 s, and 
conductance was set to 1.
II.2.2.6. Statistical texture biomarker: Statistical texture analysis has been widely used in 
medical imaging applications to characterize texture patterns within the image [28, 29, 30, 
31]. In muscular dystrophy MRI studies, dystrophic muscles usually present a unique texture 
pattern [32]. Thus, the statistical texture analysis technique has great potential to 
discriminate normal from dystrophic muscle on MRI [32,33].
In this study, we automatically generated contiguous quadrilateral volumes of interest 
(VOIs) with a fixed size (empirically chosen at 31 × 31 × 31 mm, as the average diameter of 
the proximal limb of golden retriever dogs is approximately 30 mm. Furthermore, we 
intentionally chose an odd number so that we could unambiguously determine the center 
voxel of each VOI. The distance between adjacent VOIs is 50% of the VOI size, resulting in 
50% overlap between adjacent VOIs. Areas of the VOI outside the segmented muscle were 
ignored when calculating texture features.
II.2.2.6.1. Histogram texture features—We employed standard intensity histogram-
based first-order texture features and run-length matrix-based high-order texture features to 
analyze the muscle MR images [34]. We calculated the histogram texture features on the 
(intensity calibrated) T2w image as it provides better signal than the T2fs and higher 
resolution than the T2 value maps. Given the expected difference in MR appearance, we 
calculated standard deviation (SD) of the T2w intensities [Eq. (3)] for each muscle in each 
VOI. We then calculated the average of the SD in all VOIs for each muscle. We 
hypothesized that T2w standard deviation would be higher in GRMD versus normal dogs 
and that it would change significantly across time in GRMD dogs but not in normal dogs.
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where I(x) is the intensity of voxel x, Ī is the mean intensity of a muscle in a VOI, and n is 
the number of voxels of a muscle in a VOI.
II.2.2.6.2. Three-dimensional run-length matrix features—Compared to the 
histogram texture features, the run-length matrix features take into account both the intensity 
information and spatial distribution of voxels, and thus nicely complement the histogram 
texture features.
Run-length Matrix: A gray-level ‘run’ is defined as a set of consecutive voxels of similar 
intensity level in a given direction within a predefined similarity range, commonly chosen at 
1.5% percent of the full intensity range (as determined by 64 run-length matrix bins). An 
element of a standard run-length matrix measures the number of occurrences of a run with a 
specific length and specific intensity level in a given direction. However, such direction-
specific run-lengths lack the power to characterize the 3D extension of the texture features 
in 3D MRI scans, because they only assess the intensity distribution in a single direction. In 
this study, we developed an extended method to directly measure 3D run-length matrix-
based texture features.
First, to reduce the influence of voxels with very bright intensities caused by image noise, 
the top 5 % of the intensities were set to the value of the 95th percentile. We then employed 
a grayscale 3D connected-component labeling technique to identify 3D run-length 
components with similar intensity for each muscle in each VOI. We chose a similarity range 
of 1.5 percent of the cropped intensity range. This allowed us to establish 3D run-length 
matrices for each VOI in each muscle, which assess run-lengths via 3D volumetric runs 
rather than the conventional, single-direction length measurements.
Finally, we calculated five commonly used run-length matrix features, including short run 
emphasis (SRE), long run emphasis (LRE), gray-level non-uniformity (GLN), run-length 
non-uniformity (RLN), and run percentage (RP) [34], for each muscle in each VOI. We then 
calculated the average of each feature in all VOIs for each muscle.
II.2.3. Biomarker analysis—Our quantification tool was designed to measure a set of 
MR parameters and their changes across time. Because muscle atrophy/hypertrophy, 
inflammation, and fat infiltration are characteristic histopathological features of DMD / 
GRMD, MRI derived biomarkers of interest within muscle regions included three categories 
of biomarkers: (1) muscle volume, (2) mean intensities in fat percentage (FP), water 
percentage (WP), and T2 maps, and (3) statistical texture features. These biomarkers were 
used to longitudinally and cross-sectionally assess and compare the structural tissue changes 
of GRMD dogs and normal littermates. We performed the two tailed t-test assuming unequal 
variances to evaluate the group significant differences (p-value < 0.05 was considered 
statistically significant) between normal and GRMD dogs.
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II.2.3.1. Muscle volume: Muscle volume was calculated straightforwardly from the muscle 
segmentation via voxel counting. Based on our previous studies [6, 18], we hypothesized 
that (1) most of the muscles of GRMD dogs would have smaller volumes than those of 
normal littermates; a notable exception is the CS, which is spared and may even undergo 
hypertrophy [18] followed by atrophy, with increased endomysial space due to fat and 
connective tissue; (2) muscle volumes of normal dogs would increase with age, whereas 
muscle volumes of most GRMD muscles would not increase with age or would do so at a 
lesser rate than normal dogs, again with the exception of the CS.
II.2.3.2. Intensity map based biomarkers: For the biomarkers derived from FM, WM, and 
T2 value map, we computed the arithmetic mean after the application of an erosion 
operation with a circular kernel (radius = 3 voxels) on the muscle segmentation to reduce the 
influence of partial-volume voxels. We hypothesized that (1) muscles of GRMD dogs would 
contain more fat than normal dogs and thus have higher mean intensities in FM and T2 
value map than normal dogs; (2) the mean intensities in all the biomarker maps of normal 
dogs would not change significantly with age, whereas the mean intensities of GRMD dogs 
would vary among muscles, with those for some muscles increasing and others potentially 
decreasing with age.
II.2.3.3. Statistics of texture analysis based biomarkers: For the statistical texture based 
biomarkers, we also computed the arithmetic mean on the eroded muscle segmentations. For 
these biomarkers, we hypothesized that muscles of GRMD dogs would contain more fat and 
inflammation than normal dogs and thus (1) GRMD dogs would have higher SRE, GLN, 
RLN, and RP of run-length matrix than normal dogs; (2) GRMD dogs would have lower 
LRE of run-length matrix than normal dogs; and (3) the run-length matrix features of normal 
dogs would not change significantly with age, whereas those of GRMD dogs would 
significantly change with age.
III. RESULTS
Figure 3 shows the mean value with standard error of the biomarkers of each muscle in 
normal and GRMD dogs at 3-, 6-, and 9-months of age, respectively. Normal muscles had 
consistently larger volumes (two tailed t-test assuming unequal variance for all the data of 
normal and GRMD dogs, p = 0.002) and had lower T2 value map (p < 0.001), FM (p = 
0.002), and WM (p < 0.001) values when compared to GRMD dogs at most of the age 
points, except for FM at 3-months of age. Notably, consistent with our original hypothesis, 
the GRMD CS had a larger volume than that of normal dogs. For normal dogs, the mean 
intensities in T2 value map showed a consistent decline with age, whereas the mean 
intensities in FM and WM did not change. For GRMD dogs, the mean intensities in WM 
showed a decline with age, whereas the mean intensities in FM did not change; the mean 
intensities in T2 value map also showed a significant decline between 6- and 9-months of 
age, whereas the mean intensities in T2 value map did not change over this period.
Figure 5 (a) shows the average value of SD of histogram with standard error of muscles in 
T2w of normal and GRMD dogs at 3-, 6-, and 9-months of age. Overall, the SD differed 
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significantly between normal and GRMD (p < 0.001, two tailed t-test assuming unequal 
variance).
Figures 5 (b)-(f) show the run-length matrix texture features with standard error for each 
muscle in normal and GRMD dogs at 3-, 6-, and 9-months of age, respectively. Overall, the 
SRE (p < 0.001, two tailed t-test assuming unequal variance), GLN (p < 0.001), RLN (p < 
0.001), and RP (p < 0.001) of GRMD muscles were higher while the LRE (p < 0.001) was 
lower, when compared to normal muscles at each age. With respect to longitudinal changes 
across time, the change trend for GLN and RP did not differ significantly between normal 
and GRMD muscles with age (Fig. 5 b-f), whereas, the SRE, LRE, and RLN differed 
between normal and GRMD muscles with age. In particular, the LRE of GRMD muscles 
showed a significant increment with age, whereas the LRE of normal muscles did not 
change.
Muscle segmentation is an essential step for the quantification tool. Table 2 shows the 
imaging-map-based biomarkers and volume performance calculated from the interpolation-
based muscle segmentation and reference muscle volume of two normal dogs and two 
GRMD dogs in CS, RF, and ST. The average percent error ratios over the mean intensities 
of FM, WM, and T2 value map were quite low at 1.28%, 0.73%, and 0.40%, respectively. 
We also calculated the biomarker performance from the limited-range muscle segmentation 
(only five consecutive mid-femur slices) (Table 2). The average error ratios over the mean 
intensities of FM, WM, and T2 value map were considerably higher at 28.12%, 2.70%, and 
2.95%, respectively. Overall, the errors were an order of magnitude larger in the limited-
range muscle segmentations than in the interpolated full muscle segmentations. By use of 
the paired two tailed t-test, we found that the errors were significantly higher in the limited-
range muscle segmentation than in the interpolated full muscle segmentation (p = 0.001, p = 
0.04, p = 0.04 for fat map, water map, and T2 value map, respectively).
In order to test whether the above results may be true in GRMD only, we investigated the 
relative error-rates of biomarkers in GRMD (RGRMD) versus normal (Rnormal) dogs by 
calculating the ratio between RGRMD and Rnormal, i.e., RGRMD / Rnormal. The ratios for FM, 
WM and T2 value of the segmentation in mid-femur slices were 0.72, 5.85, and 1.10, 
respectively; the ratios for fat map, water map and T2 value of the interpolation-based whole 
muscle segmentation were 1.06, 4.10, and 0.98, respectively. These results do not show 
obvious evidence to support that the elevated error rates are present only in GRMD. 
Furthermore, we also calculated the difference of biomarkers derived from interpolation-
based full muscle segmentation and the limited range muscle segmentation over all normal 
dog scans in our study for cranial sartorius (CS), femoris (RF), and semitendinosus (ST). 
The result shows a comparable error levels (21.27%, 4.80%, and 2.94% for fat map, water 
map, and T2 value, respectively) to the ones shown in Table 2 (28.12%, 2.70%, and 2.95% 
for fat map, water map, and T2 value, respectively). While there is no ground truth full 
muscle segmentation available for all these scans, it can safely be said that the interpolation-
based full muscle and mid-femur limited muscle biomarkers show large differences. Given 
that the interpolation-based full muscle segmentation showed clearly better performance 
when compared to cases with ground truth, this indicates that limiting the segmentation to a 
small range introduces significant variation/errors in MR biomarker measurements. Thus, 
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the interpolation-based whole muscle segmentation scheme allowed us to compute fairly 
stable and accurate values for the biomarkers, whereas the limited range segmentation based 
measures show higher variance and errors. .
We also investigated the segmentation inter-rater variability between ZF and JW on the 
semi-automatic segmentation scheme (Table 3). The comparison results showed that the 
average performance across raters over mean intensities in FM, WM, and T2 value map 
were appropriately low at 6.36%, 5.28%, and 1.21%, respectively. The inter-rater variability 
for normal and GRMD dogs showed similar performance (p > 0.99, paired two tailed t-test). 
This relatively small inter-rater difference indicates that our biomarker quantification tool is 
reliable and stable.
IV.DISCUSSION
Muscle segmentation plays an important role in DMD MRI biomarker quantification. The 
results from our study demonstrated that MRI biomarkers computed from the muscle 
regions determined by semi-automatic full muscle segmentation have a lower error rate than 
biomakers from regions determined by the standard limited range manual muscle 
segmentations (5 mid-femur slices) [9, 10, 35]. For the muscle volume, one could expect 
that full muscle segmentation would provide more accurate measurement results than in 
limited range segmentation. The magnitude of the error observed in the other biomarkers 
was more surprising. This result is likely due to the inhomogeneous nature of muscle lesions 
in DMD / GRMD subjects. Furthermore, it strongly highlights that the whole or at least a 
large segment of the muscle should ideally be segmented to miminize sampling error, while 
excluding irrelevant surrounding tissues. Our experimental results showed that a 
straightforward interpolation scheme allowed computation of a fairly stable and accurate set 
of MRI biomarkers. Although the muscles of normal dogs may contain less heterogeneity, 
the quantification at mid-femur of normal dogs still may not be optimal, because not all the 
muscles are growing along the entire femur bone. For instance, the mid-femoral point is 
generally the distal of gracilis. Because the sectional area of the distal is small, the 
quantification would be easily affected by the human errors (muscle segmentation) and 
image noises. Therefore, whole muscle volume based biomarker quantification is highly 
recommended for the muscular dystrophic studies.
The overall computational scheme of this tool is composed of “automatic” and “interactive” 
processing steps. The automatic processing part consists of the pre-processing and 
biomarker calculation. The average automatic processing time is about 15 minutes / scan 
(CentOS 5.6 Linux, Intel 64 bit 1.66GHz quad-core, 128GB RAM). The interactive 
processing part consists of the muscle segmentation and identification of subcutaneous fat 
regions, in which muscle segmentation is the most labor-intensive task. Manual full muscle 
segmentation for each muscle would require an average of 60 minutes, whereas the semi-
automatic muscle segmentation for each muscle, including the manual delineation of muscle 
regions in every 5th slice and the automatic segmentation interpolation, averaged less than 
15 minutes. Our experimental results indicate that the target segmentation accuracy 
requirements of the automatic muscle segmentation are relatively relaxed, as the GRMD 
biomarkers could be estimated fairly stably in the presence of smaller segmentation errors 
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(as were likely present in these semi-automatic segmentations). In our ongoing research, we 
are investigating the use of fully automatic multi-atlas-based muscle segmentation schemes.
While fat ultimately increases histologically in both DMD and GRMD, the relatively young 
age of these dogs and short 6–9 month time course of the study may not have been sufficient 
to capture more chronic fatty infiltration. Another potential reason is the inherently large 
variability of the fat measures in images acquired with the selected fat suppression-based 
MR protocols. Ultimately spectroscopic methods such as proton MR spectroscopy may be 
more sensitive to these early, small changes in lipid levels at low fat fractions.
The T2 value maps covered the mid-femur section of the proximal pelvic limbs (Section II. 
1). As described above, MRI biomarkers calculated from full muscle segmentation show 
considerably less error than from limited range muscle segmentations. Thus, a T2 value map 
should ideally cover the entire length of a muscle or at least a large segment of the muscle to 
maximize the number of pixels included in the calculation. As a result of experiments 
presented here, we modified our imaging protocol in ongoing studies such that the T2FIT 
sequence (used for calculating T2 value map) covers the full proximal pelvic limb, while 
adjusting the slice thickness and number of echoes to keep a comparable scan time (TR 3000 
ms / TE 10, 20, 30, 40, 50 ms; slice thickness 7 mm; 30 slices per echo). We have tested the 
modified imaging protocol on two GRMD dogs (see Table 4 for T2 value based biomarker 
results). The average biomarker difference between limited and full muscle segmentations 
for T2 value map was 15.14% (p < 0.0001, paired two tailed t-test). The smallest muscles 
had the greatest difference between the two methods. This suggests that the T2-value-based 
biomarker should also be assessed within the full muscle or include enough pixels within a 
given muscle to minimize the effects of sampling error.
We observed that T2w and T2fs images generally contain higher intensity inhomogeneities 
than the T2 value maps. Although we applied the N4 algorithm to correct intensities, the 
strong intensity inhomogeneity in T2w and T2fs could not be completely eliminated. 
Furthermore, the T2w and T2fs images were calibrated using manually- identified 
subcutaneous fat. Because the manual identification of subcutaneous fat is subject to human 
rater error, the intensity calibration may not be fully accurate. It was, therefore, not 
surprising to find that the inherently intensity calibrated T2 value map based biomarkers 
were more reliable than those of our fat and water map based biomarkers.
Although the statistical texture analysis technique has been used in many imaging 
applications of muscle diseases, to our knowledge, it has not been widely used for studies of 
muscular dystrophy. One characteristic histopathologic feature of DMD and GRMD is the 
patchy, inhomogeneous and differential involvement of lesions within even the same 
muscle. The commonly used mean intensity marker will not be sufficiently sensitive to 
capture this characteristic inhomogeneity. In this study, we employed histogram features and 
adapted 3D run-length matrix features to investigate the difference in MR appearance of 
normal and GRMD muscles cross-sectionally and longitudinally across time. Because of 
fatty change , one would expect GRMD muscles to have coarser texture than normal 
muscles. Therefore, the affected muslces would have more short runs, less long runs, and a 
higher total number of runs than normal muscles. Furthermore, because muscle lesions are 
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irregular, the uniformity in the distribution of runs over grey levels and over the lengths of 
runs would generally be higher in affected versus normal muscles. For these reasons, the 
run-length matrix features distinguished GRMD from normal muscles. Overall, the 
statistical texture biomarkers had advantages in quantifying group differences for the 
GRMD and normal dogs and longitudinal disease progression in GRMD dogs, suggesting 
that these biomarkers will be useful in DMD clinical trials.
In this study, we proposed several MRI derived biomarkers and statistical texture analysis 
based biomarkers. Histopathologic / functional correlation would be required to validate 
these markers and is ongoing, using functional indices of isometric distal limb force [37] and 
repeated eccentric contractions; muscle weight; and histopathological measures of myofiber 
and endomysial space (non-contractile tissue) per unit area [38, 39].. In this paper, we 
focused on developing a biomarker quantification tool. Thus, validation of the proposed 
biomarkers using histopathologic / functional findings is outside the paper’s scope and will 
be described separately..
As a final note, we plan to disseminate this biomarker quantification tool publicly as open 
source on NIH’s Neuro-Imaging Toolkit and Resource Clearinghouse (NITRC, http://
www.nitrc.org/). We hope this quantification tool will constitute a valuable resource for the 
DMD research community.
V.CONCLUSIONS
In this study, we developed a semi-automatic MRI biomarker quantification tool 
incorporating enhanced histogram based statistical features and novel 3D run-length matrix 
based statistical texture biomarkers in the GRMD model of DMD. Our quantification tool 
showed clear group differences for the affected and normal dogs and longitudinal disease 
progression in affected dogs, albeit with operator input for the segmentation of muscles and 
subcutaneous fat regions. Our quantification tool provided useful MRI biomarkers for 
GRMD. However, it also had some limitations: (i) the muscle segmentation method was not 
fully automated and required human rater input; (ii) the subcutaneous fat regions were 
identified manually for the intensity calibration; and (iii) the intensity inhomogeneous 
correction was imperfect. In our ongoing research, we are focusing on development of fully 
automatic muscle segmentation techniques to promote efficiency and reliability of our 
scheme.
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MRI scan of the proximal pelvic limb at mid-thigh of a normal control dog in transverse 
view. (a) T2-weighted (T2W) image and. (b) T2-weighted fat suppressed (T2fs) image, and 
(c) the transverse view of a T2 value map derived from T2FIT.
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(a) Manual muscle segmentation of ST = semitendinosus (yellow), RF = rectus femoris 
(red), CS = cranial sartorius (light blue), AD = adductor magnus (blue), GR = gracilis 
(pink), and BF = biceps femoris (brown) in a transverse view and (b) linearly interpolated 
muscle volumes in 3D view.
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The relationship between age and the average value of aveage value of (a) muscle volume 
(two tailed t-test assuming unequal variance for all the data of normal and GRMD dogs, p = 
0.002), (b) fat map (p = 0.002), (c) water map (p < 0.001), and (d) T2 value (p < 0.001) for 
normal and GRMD dogs with standard errors.
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The relationship between age and the average value of each histogram and run-length matrix 
texture feature for normal and GRMD dogs with standard errors. (a) standard deviation of 
histogram (two tailed t-test assuming unequal variance for all the data of normal and GRMD 
dogs, p < 0.001), (b) SRE (p < 0.001), (c) LRE (p < 0.001), (d) GLN (p < 0.001), (e) RLN (p 
< 0.001), and (f) RP (p < 0.001).
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Table 3
Inter-rater variability: biomarker differences of cranial sartorius (CS), rectus femoris (RF), semitendinosus 
(ST), biceps femoris (BF), gracilis (GR), and adductor magnus (AD) between ZF and JW’s segmentation.
Fat Map Water Map T2 Value
CS 7.63% 5.05% 4.22%
RF 8.47% 4.11% 0.78%
ST 5.56% 0.69% 0.66%
BF 2.48% 0.42% 0.41%
GR 9.74% 1.03% 1.04%
AD 4.26% 0.28% 0.14%
Average 6.36% 1.93% 1.21%
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Table 4
The average T2 value map-based biomarkers of cranial sartorius (CS), rectus femoris (RF), semitendinosus 
(ST), biceps femoris (BF), gracilis (GR), and adductor magnus (AD) calculated in the entire proximal pelvic 
limb T2 value map and mid-femur T2 value map.
T2 Value
Entire proximal
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